Cite

HARVARD Citation

    Worrillow, L. et al. (2008). Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma. Journal of medical genetics. 45 (3), pp. 142-146. [Online]. 
  
Back to record